[ad_1] Daclatasvir combined with sofosbuvir and ribavirin resulted in similar sustained virologic response rates in patients with genotype 2 and 3 hepatitis C compared to those treated with sofosbuvir and velpatasvir. This …
Read More »Hepatitis C, in real life, efficacy similar to that of daclatavir sofosbuv
